Constantine Davides
Stock Analyst at Citizens
(0.91)
# 3,920
Out of 5,182 analysts
121
Total ratings
26.79%
Success rate
-23.72%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Initiates: Market Outperform | $18 | $14.14 | +27.30% | 1 | Apr 14, 2026 | |
| AMN AMN Healthcare Services | Maintains: Market Outperform | $22 → $24 | $20.19 | +18.87% | 14 | Feb 23, 2026 | |
| PGNY Progyny | Upgrades: Market Outperform | $30 | $18.12 | +65.56% | 4 | Jan 20, 2026 | |
| OPCH Option Care Health | Reiterates: Market Outperform | $36 → $38 | $28.82 | +31.85% | 8 | Jan 13, 2026 | |
| EVH Evolent Health | Maintains: Market Outperform | $11 → $10 | $2.84 | +252.11% | 12 | Jan 6, 2026 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $86.04 | +41.79% | 6 | Dec 4, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $24.02 | +29.06% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $7.17 | +234.73% | 11 | Nov 7, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $25.80 | +86.05% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $94.32 | +59.03% | 4 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $14.37 | - | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $6.22 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $30.05 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $76.57 | +47.58% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $38.50 | -32.47% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $182.36 | +35.99% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $21.73 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $9.86 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.37 | +283.21% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $1.10 | +11,263.64% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $26.06 | -42.44% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $24.24 | -7.18% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.07 | +176.87% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.73 | +1,817.81% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.44 | +82,279.86% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.39 | +232,993.53% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $0.74 | +5,287.93% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.18 | +3,255.70% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.56 | +51,182.05% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $597,600 → $298,800 | $2.47 | +12,097,065.99% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.14 | +62,171.06% | 2 | Sep 23, 2022 |
Omada Health
Apr 14, 2026
Initiates: Market Outperform
Price Target: $18
Current: $14.14
Upside: +27.30%
AMN Healthcare Services
Feb 23, 2026
Maintains: Market Outperform
Price Target: $22 → $24
Current: $20.19
Upside: +18.87%
Progyny
Jan 20, 2026
Upgrades: Market Outperform
Price Target: $30
Current: $18.12
Upside: +65.56%
Option Care Health
Jan 13, 2026
Reiterates: Market Outperform
Price Target: $36 → $38
Current: $28.82
Upside: +31.85%
Evolent Health
Jan 6, 2026
Maintains: Market Outperform
Price Target: $11 → $10
Current: $2.84
Upside: +252.11%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $86.04
Upside: +41.79%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $24.02
Upside: +29.06%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $7.17
Upside: +234.73%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $25.80
Upside: +86.05%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $94.32
Upside: +59.03%
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $14.37
Upside: -
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $6.22
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $30.05
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $76.57
Upside: +47.58%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $38.50
Upside: -32.47%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $182.36
Upside: +35.99%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $21.73
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $9.86
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.37
Upside: +283.21%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $1.10
Upside: +11,263.64%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $26.06
Upside: -42.44%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $24.24
Upside: -7.18%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.07
Upside: +176.87%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $0.73
Upside: +1,817.81%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $0.44
Upside: +82,279.86%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.39
Upside: +232,993.53%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $0.74
Upside: +5,287.93%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.18
Upside: +3,255.70%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.56
Upside: +51,182.05%
Sep 28, 2022
Maintains: Buy
Price Target: $597,600 → $298,800
Current: $2.47
Upside: +12,097,065.99%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.14
Upside: +62,171.06%